| Year |
Citation |
Score |
| 2021 |
Nchinda GW, Al-Atoom N, Coats MT, Cameron JM, Waffo AB. Uniqueness of RNA Coliphage Qβ Display System in Directed Evolutionary Biotechnology. Viruses. 13. PMID 33801772 DOI: 10.3390/v13040568 |
0.274 |
|
| 2021 |
Jones LB, Kumar S, Bell CR, Crenshaw BJ, Coats MT, Sims B, Matthews QL. Lipopolysaccharide Administration Alters Extracellular Vesicles in Cell Lines and Mice. Current Microbiology. PMID 33559732 DOI: 10.1007/s00284-021-02348-5 |
0.376 |
|
| 2020 |
Sahu R, Dixit S, Verma R, Duncan SA, Coats MT, Giambartolomei G, Singh SR, Dennis VA. A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4 effector (CD44 CD62L) and memory (CD44 CD62L) T-cells in immunized mice. Nanomedicine : Nanotechnology, Biology, and Medicine. 102257. PMID 32610072 DOI: 10.1016/J.Nano.2020.102257 |
0.392 |
|
| 2019 |
Jones LB, Kumar S, Bell CR, Peoples VA, Crenshaw BJ, Coats MT, Scoffield JA, Rowe GC, Sims B, Matthews QL. Effects of on Microglial-Derived Extracellular Vesicle Biogenesis and Composition. Pathogens (Basel, Switzerland). 8. PMID 31847332 DOI: 10.3390/Pathogens8040297 |
0.439 |
|
| 2018 |
Singleton RL, Sanders CA, Jones K, Thorington B, Egbo T, Coats MT, Waffo AB. Function of the RNA Coliphage Qβ Proteins in Medical In Vitro Evolution. Methods and Protocols. 1. PMID 31164561 DOI: 10.3390/mps1020018 |
0.361 |
|
| 2018 |
Dennis EA, Coats MT, Griffin S, Pang B, Briles DE, Crain MJ, Swords WE. Hyperencapsulated Mucoid Pneumococcal Isolates from Patients with Cystic Fibrosis Have Increased Biofilm Density and Persistence In vivo. Pathogens and Disease. PMID 30265307 DOI: 10.1093/Femspd/Fty073 |
0.644 |
|
| 2018 |
Jones LB, Bell CR, Bibb KE, Gu L, Coats MT, Matthews QL. Pathogens and Their Effect on Exosome Biogenesis and Composition. Biomedicines. 6. PMID 30041409 DOI: 10.3390/Biomedicines6030079 |
0.389 |
|
| 2017 |
Dosunmu EF, Emeh RO, Dixit S, Bakeer MK, Coats MT, Owen DR, Pillai SR, Singh SR, Dennis VA. The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways. Plos One. 12: e0176640. PMID 28467446 DOI: 10.1371/Journal.Pone.0176640 |
0.427 |
|
| 2016 |
Coats MT. Combating Malaria: Where do We Stand? Journal of Infectious Disease and Therapy. 4. PMID 27066523 DOI: 10.4172/2332-0877.1000270 |
0.346 |
|
| 2015 |
Dennis EA, Coats MT, Griffin SE, Hale JY, Novak L, Briles DE, Crain MJ. The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease. Plos One. 10: e0140335. PMID 26469863 DOI: 10.1371/Journal.Pone.0140335 |
0.646 |
|
| 2014 |
Bibbs RK, Harris RD, Peoples VA, Barnett C, Singh SR, Dennis VA, Coats MT. Silver polyvinyl pyrrolidone nanoparticles exhibit a capsular polysaccharide influenced bactericidal effect against Streptococcus pneumoniae. Frontiers in Microbiology. 5: 665. PMID 25520713 DOI: 10.3389/Fmicb.2014.00665 |
0.426 |
|
| 2012 |
Croney CM, Coats MT, Nahm MH, Briles DE, Crain MJ. PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine. Clinical and Vaccine Immunology : Cvi. 19: 891-6. PMID 22539473 DOI: 10.1128/Cvi.05671-11 |
0.515 |
|
| 2011 |
Coats MT, Murphy T, Paton JC, Gray B, Briles DE. Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. Microbial Pathogenesis. 50: 343-9. PMID 21377521 DOI: 10.1016/J.Micpath.2011.02.010 |
0.646 |
|
| 2005 |
Coats MT, Benjamin WH, Hollingshead SK, Briles DE. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae. Vaccine. 23: 4257-62. PMID 16005736 DOI: 10.1016/J.Vaccine.2005.03.039 |
0.65 |
|
| Show low-probability matches. |